2005
DOI: 10.1053/j.ajkd.2005.01.008
|View full text |Cite
|
Sign up to set email alerts
|

Causes of reversible nephrogenic diabetes insipidus: A systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
61
0

Year Published

2008
2008
2015
2015

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 111 publications
(68 citation statements)
references
References 85 publications
1
61
0
Order By: Relevance
“…However, most NDI is not inherited, but rather results from either exogenous causes (e.g. lithium, demeclocycline) or renal disease [73,74]. In pediatric patients, NDI be a concomitant of obstructive uropathy [3,75].…”
Section: Nephrogenic Diabetes Insipidus (Ndi)mentioning
confidence: 99%
“…However, most NDI is not inherited, but rather results from either exogenous causes (e.g. lithium, demeclocycline) or renal disease [73,74]. In pediatric patients, NDI be a concomitant of obstructive uropathy [3,75].…”
Section: Nephrogenic Diabetes Insipidus (Ndi)mentioning
confidence: 99%
“…The high load of calcium that needed to be excreted could have led to nephrogenic diabetic insipidus and polydipsia to compensate for the increased fluid loss. In a systematic review of causes of reversible nephrogenic diabetes insipidus by Garofeanu et al, 16 hypercalcemia as a cause of polyuria was noted. There was no association between constipation and hypercalcemia or hypercalciuria in our study.…”
Section: Discussionmentioning
confidence: 99%
“…Acquired nephrogenic DI is typically related to either AVP resistance at the site of action in the distal tubule or collecting ducts or interference in the medullary countercurrent mechanism, causing impaired renal concentrating capacity. Lithium toxicity and metabolic abnormalities, particularly hypokalemia and hypercalcemia, are the most common causes of acquired nephrogenic DI, but numerous other etiologies have been implicated 82 (Table 6). Long-term lithium therapy can lead to polyuria and impaired renal concentrating defects in an estimated 20-30% of patients and DI in 10-12% of patients, due to the down-regulation of AVP-2 receptors and/or reduced expression of AQP-2 channels.…”
Section: Diabetes Insipidusmentioning
confidence: 99%